Workflow
一品红: 北京市中伦(广州)律师事务所关于一品红药业集团股份有限公司2025年第二次临时股东大会的法律意见书

Core Viewpoint - The legal opinion letter confirms the legality of the procedures and results of the 2025 Second Extraordinary General Meeting of Yipinhong Pharmaceutical Group Co., Ltd. [1][4][10] Group 1: Meeting Procedures - The meeting was convened by the fourth board of directors on June 14, 2025, and the notice was published on June 16, 2025, in compliance with relevant laws and regulations [4][5]. - The meeting was held on July 1, 2025, at 14:30, with a total of 7 shareholders present, representing 271,932,523 shares [5][6]. - The network voting was conducted on the same day, with 213 shareholders participating, representing 24,622,599 shares, which is 5.5136% of the total voting shares [7]. Group 2: Voting Results - The first resolution regarding the acquisition of minority shares from a controlling subsidiary was approved with 24,640,090 votes in favor, accounting for the majority of the votes [8][9]. - The second resolution concerning the use of idle funds for cash management was also approved with 295,895,480 votes in favor, indicating strong support from shareholders [9][10]. - The voting procedures were verified and deemed compliant with the relevant laws and regulations, confirming the legitimacy of the results [10].